Abstract:Background: CDKL5 Deficiency Disorder (CDD) is a rare genetic disorder caused by a mutation in the cyclin-dependent kinase-like 5 (CDKL5) gene. It is now considered to be a developmental and epileptic encephalopathy because of the early onset of seizures in association with severe global delay. Other features include cortical visual impairment, sleep and gastro-intestinal problems. Progress in clinical understanding, especially regarding the spectrum of functional ability, seizure patterns, and other comorbidities was initially slow but accelerated in 2012 with the establishment of the International CDKL5 Database (ICDD). Our aim was to use this data source to investigate quality of life (QOL) and associated factors in this disorder. Method: A follow-up questionnaire was administered in 2018 to parents of children registered with the ICDD who had a pathogenic CDKL5 variant. QOL was assessed using QI Disability, an instrument, specifically developed to measure total and specific domains of QOL (physical health, positive emotions, negative emotions, social interaction, leisure and the outdoors (leisure) and independence) in children with intellectual disability. Associations with functional abilities, physical health, mental health and family factors were investigated, initially using univariate analyses followed by multivariate analyses for each of these groups with a final composite model which included the important variables identified from previous models. Results: Questionnaires were returned by 129/160 families with a child aged >3 years. Functional impairment, including lack of ability to sit, use hands and communicate had the greatest adverse impact on QOL. There were also some relationships with major genotype groupings. Individuals using three or more anti-epileptic medications had poorer QOL than those on one or no medication, particularly in the physical health domain. There was also variation by geographical region with those living in North America typically having the best QOL and those living in middle or lower income countries poorer QOL. Conclusion: Although lower functional abilities were associated with poorer quality of life further research is needed to understand how environmental supports might mitigate this deficit. Comprehensive care and support for both the child and family have important roles to play in helping families to thrive despite the severity of CDD.

CDKL5 Deficiency Disorder: Some Lessons Learned 20 Years After the First Description

Deletions in the CDKL5 5′ untranslated region lead to CDKL5 deficiency disorder

Longitudinal, multidimensional, observational study of 15 patients with CDKL5 Deficiency Disorder

CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment

Novel CDKL5 targets identified in human iPSC-derived neurons

CDKL5 deficiency disorder: Relationship between genotype, epilepsy, cortical visual impairment, and development

CDKL5 deficiency-related neurodevelopmental disorders: a multi-center cohort study in Italy

Novel CDKL5 Mutations Were Found in Patients in China: Retrospective Investigation in Cases of CDKL5-related Disorders

Research progress on the pathogenesis of CDKL5 pathogenic variants and related encephalopathy

Temporal manipulation of Cdkl5 reveals essential postdevelopmental functions and reversible CDKL5 deficiency disorder–related deficits

Exploring quality of life in individuals with a severe developmental and epileptic encephalopathy, CDKL5 Deficiency Disorder

Delineation of Structural Rearrangements as an Overlooked Recurrent Pathological Mechanism

Report of 7 CDKL5 disorder cases

The CDKL5 kinase undergoes liquid-liquid phase separation driven by a serine-rich C-terminal region and impaired by neurodevelopmental disease-related truncations

Discovery and characterization of a specific inhibitor of serine-threonine kinase cyclin-dependent kinase-like 5 (CDKL5) demonstrates role in hippocampal CA1 physiology

Preclinical studies of gene replacement therapy for CDKL5 deficiency disorder

Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: A Calcium Channelopathy?

Communication of individuals with CDKL5 deficiency disorder as observed by caregivers: A descriptive qualitative study

Enhanced hippocampal LTP but normal NMDA receptor and AMPA receptor function in a rat model of CDKL5 deficiency disorder

Expanding the phenotypic spectrum for CDK8‐related disease: A case report

Loss of CDKL5 in Glutamatergic Neurons Disrupts Hippocampal Microcircuitry and Leads to Memory Impairment in Mice